Key Insights

Highlights

Treatment Research

1 treatments under study, led by Peripheral Blood Sampling

Research Leaders

8 sponsors active, led by Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting2
Active Not Recruiting2

Clinical Trials (4)

Showing 4 of 4 trials
NCT06692127Active Not Recruiting

DETECTion of the Prevalence of Silent Atherosclerosis Across Adult Life - Phase I of REACT

NCT07628088Active Not RecruitingPrimary

AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images

NCT07504679Not ApplicableNot Yet RecruitingPrimary

Adipose Visceral and Epicardial Risk Evaluation

NCT07412457Not Yet Recruiting

Guideline Adherence in Dyslipidemia With Clinical Decision Support

Showing all 4 trials

Research Network

Common Treatments

  • Peripheral Blood Sampling1

Active Sponsors

  • Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • Gødstrup Hospital1
  • Novo Nordisk Foundation1
  • Herlev and Gentofte Hospital1

Top Investigators

Related Conditions

  • Cardiovascular Risk2
  • Cardiovascular Diseases1
  • Atherosclerosis1
  • Coronary Artery Disease1
  • Dyslipidemia1

Activity Timeline